Renal and glycemic effects of high-dose chromium picolinate in db/db mice: Assessment of DNA damage

Journal of Nutritional Biochemistry

Volumn 23, Issue 8, 2012, Pages 977-985

  Mozaffari, Mahmood S ^a   Baban, Babak ^a   Abdelsayed, Rafik ^a   Liu, Jun Yao ^a   Wimborne, Hereward ^a   Rodriguez, Nancy ^a   Abebe, Worku ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

H2AX; 8 OHdG; Albuminuria; Chromium picolinate; Diabetes; Kidney

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ADVANCED GLYCATION END PRODUCT; CHROMIUM PICOLINATE; CREATININE; DNA; GLUCOSE; HEMOGLOBIN A1C; HISTONE H2AX; HISTONE H2AX GAMMA; INSULIN; UNCLASSIFIED DRUG;

ALBUMINURIA; ANIMAL EXPERIMENT; ARTICLE; CELL EXPANSION; CONTROLLED STUDY; CREATININE CLEARANCE; DIET SUPPLEMENTATION; DNA DAMAGE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY PARENCHYMA; MALE; MESANGIUM CELL; MOUSE; NONHUMAN;

ALBUMINURIA; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; GLYCOSYLATION END PRODUCTS, ADVANCED; HISTONES; INSULIN; KIDNEY; MALE; MICE; PICOLINIC ACIDS;

MUS;

EID: 84864026066     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.05.004     Document Type: Article

References (41)

1. Anderson R.A. Chromium in the prevention and control of diabetes. Diabetes Metab 2000, 26:22-27.
2. Vincent J.B. Mechanisms of chromium action: low-molecular-weight chromium-binding substance. J Am Coll Nutr 1999, 18(1):6-12.
3. Wang Z.Q., Zhang X.H., Russell J.C., Hulver M., Cefalu W.T. Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats. J Nutr 2006, 136:415-420.
4. Qiao W., Peng Z., Wang Z., Wei J., Zhou A. Chromium improves glucose uptake and metabolism through upregulating the mRNA levels of IR, GLUT4, GS, and UCP3 in skeletal muscle cells. Biol Trace Elem Res 2009, 131(2):133-142.
5. Wang Y., Yao M. Effects of chromium picolinate on glucose uptake in insulin-resistant 3T3-L1 adipocytes involve activation of p38 MAPK. J Nutr Biochem 2009, 20:982-991.
6. Cefalu W.T., Hu F.B. Role of chromium in human health and in diabetes. Diabetes Care 2004, 11:2741-2751.
7. Sheetz M.J., King G.L. Molecular understanding of hyperglycemia's adverse effects of diabetic complications. JAMA 2002, 288(20):2579-2588.
8. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54:1615-1625.
9. Mozaffari M.S., Abdelsayed R., Schaffer S.W. Diabetic complications: pathogenic mechanisms and prognostic indicators. Predictive diagnostics and personalized treatment: dream or reality 2009, 157-182. Golubnitschaja O Nova Publishers.
10. Stearns D.M., Wise J.P., Patierno S.R., Wetterhahn K.E. Chromium (III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J 1995, 9:1643-1648.
11. Stallings D.M., Hepburn D.D., Hannah M., Vincent J.B., O'Donnell J. Nutritional supplement chromium picolinate generates chromosomal aberrations and impedes progeny development in Drosophila melanogaster. Mutat Res 2006, 610:101-113.
12. Snow E.T. Effects of chromium on DNA replication in vitro. Environ Health Perspect 1994, 102:41-44.
13. Bridgewater L.C., Manning F.C., Woo E.S., Patierno S.R. DNA polymerase arrest by adducted trivalent chromium. Mol Carcinog 1994, 9:122-133.
14. Speetjens J.K., Collins R.A., Vincent J.B., Woski S.A. The nutritional supplement chromium(III) Tris(picolinate) cleaves DNA. Chem Res Toxicol 1999, 12:483-487.
15. Coryell V.H., Stearns D.M. Molecular analysis of hprt mutations induced by chromium picolinate in CHO AA8 cells. Mutat Res 2006, 610:114-123.
16. Bagchi D., Bagchi M., Balmoori J., Ye X., Stohs S.J. Comparative induction of oxidative stress in cultured J774A.1 macrophage cells by chromium picolinate and chromium nicotinate. Res Commun Mol Pathol Pharmacol 1997, 97:335-346.
17. Stout M.D., Nyska A., Collins B.J., Witt K.L., Kissling G.E., Malarkey D.E., et al. Chronic toxicity and carcinogenicity studies of chromium picolinate monohydrate administered in feed to F344/N rats and B6C3F1 mice for 2 years. Food Chem Toxicol 2009, 47:729-733.
18. Cadet J., Delatour T., Douki T., Gasparutto D., Pouget J.P., Ravanat J.L., et al. Hydroxyl radicals and DNA base damage. Mutat Res 1999, 424:9-21.
19. Hepburn D.D., Vincent J.B. In vivo distribution of chromium from chromium picolinate in rats and implications for the safety of the dietary supplement. Chem Res Toxicol 2002, 15(2):93-100.
20. Hepburn D.D., Vincent J.B. Tissue and subcellular distribution of chromium picolinate with time after entering the bloodstream. J Inorg Biochem 2003, 94:86-93.
21. Lamson D.W., Plaza S.M. The safety and efficacy of high-dose chromium. Altern Med Rev 2002, 7(3):218-235.
22. Diaz M.L., Watkins B.A., Li Y., Anderson R.A., Campbell W.W. Chromium picolinate and conjugated linoleic acid do not synergistically influence diet- and exercise-induced changes in body composition and health indexes in overweight women. J Nutr Biochem 2008, 19:61-68.
23. Sharma K., McCue P., Dunn S.R. Diabetic kidney disease in db/db mouse. Am J Physiol Renal Physiol 2003, 284:F1138-F1144.
24. Like A.A., Lavine R.L., Poffenbarger P.L., Chick W.L. Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria. Am J Pathol 1972, 66:193-224.
25. Koya D., Haneda M., Nakagawa H., Isshiki K., Sato H., Maeda S., et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 2000, 14(3):439-447.
26. Levine D.Z., Iacovitti M., Robertson S.J., Mokhtar G.A. Modulation of single-nephron GFR in the db/db mouse model of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 2006, 290:R975-R981.
27. Chin M., Isono M., Isshiki K., Araki S., Sugimoto T., Guo B., et al. Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db mice. Am J Pathol 2005, 166(6):1629-1636.
28. Wu L.L., Chiou C.C., Chang P.Y., Wu J.T. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004, 339:1-9.
29. Mah L.J., El-Osta A., Karagiannis T.C. γH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 2010, 24:679-686.
30. Mozaffari M.S., Abdelsayed R., Liu J.Y., Wimborne H., El-Remessy A., El-Marakby A. Effects of chromium picolinate on glycemic control and kidney of the obese Zucker rat. Nutr Metab 2009, 6:51.
31. Gudi R., Slesinski R.S., Clarke J.J., San R.H. Chromium picolinate does not produce chromosome damage in CHO cells. Mutat Res 2005, 587:140-146.
32. Slesinski R.S., Clarke J.J., San R.H., Gudi R. Lack of mutagenicity of chromium picolinate in the hypoxanthine phosphoribosyltransferase gene mutation assay in Chinese hamster ovary cells. Mutat Res 2005, 585(1-2):86-95.
33. Andersson M.A., Petersson Grawé K.V., Karlsson O.M., Abramsoon-Zetterberg L.A., Hellman B.E. Evaluation of the potential genotoxicity of chromium picolinate in mammalian cells in vivo and in vitro. Food Chem Toxicol 2007, 45(7):1097-1106.
34. Komorowski J.R., Greenberg D., Juturu V. Chromium picolinate does not produce chromosome damage. Toxicol In Vitro 2008, 22:819-826.
35. Iqbal N., Cardillo S., Volger S., Bloedon L.T., Anderson R.A., Boston R., et al. Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults. Metab Syndr Relat Disord 2009, 7(2):143-150.
36. Martin J., Wang Z.Q., Zhang X.H., Wachtel D., Volaufova J., Matthews D.E., et al. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care 2006, 29:1826-1832.
37. Kleefstra N., Houweling S.T., Jansman F.G., Groenier K.H., Gans R.O., Meyboom-de Jong B., et al. Chromium treatment has no effect in patients with poorly controlled insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care 2006, 29(3):521-525.
38. Ruggenenti P., Remuzzi G. Time to abandon microalbuminuria?. Kidney Int 2006, 70:1214-1222.
39. Singh A, Satchell SD. Microalbuminuria: causes and implications. Pediatr Nephrol [Epub ahead of print].
40. Nelson R.G., Bennett P.H., Beck G.J., Tan M., Knowler W.C., Mitch W.E., et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med 1996, 335(22):1636-1642.
41. Jain S.K., Rains J.L., Croad J.L. Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med 2007, 43:1124-1131.